Esil Aleyd
FcαRI as therapeutic target to reduce IgA-induced neutrophil activation
Thesis defense: 2-7-2017
Promotores: prof. dr. M. van Egmond. Copromotor:: dr. J.E. Bakema
Thesis defense: 2-7-2017
Promotores: prof. dr. M. van Egmond. Copromotor:: dr. J.E. Bakema
